Nitazoxanide 500mg oral tablet    (DrugBank: Nitazoxanide)

2 diseases
IDDisease name (Link within this page)Number of trials
96Crohn disease0
97Ulcerative colitis1

96. Crohn disease    [ 2,209 clinical trials,   1,276 drugs,   (DrugBank: 240 drugs),   166 drug target genes,   210 drug target pathways]
Searched query = "Crohn disease", "Terminal ileitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: . Trials are sorted by Date_enrollment from most recent to oldest in the table.
0 / 2,209 trial found

97. Ulcerative colitis    [ 2,269 clinical trials,   1,331 drugs,   (DrugBank: 241 drugs),   114 drug target genes,   181 drug target pathways]
Searched query = "Ulcerative colitis"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
1 / 2,269 trial found
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT03441893
(ClinicalTrials.gov)
January 1, 20158/2/2018Role of Intestinal Protozoa and Helminths in the Course of Ulcerative ColitisRole of Intestinal Protozoa and Helminths in the Course of Ulcerative ColitisUlcerative Colitis;Ulcerative Colitis Exacerbation;Protozoan Infections;Helminth InfectionDiagnostic Test: parasitological diagnostics (coproscopy);Drug: Nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250Mg Tablet and nitazoxanide 500Mg Oral Tablet;Drug: Mesalazine 250MgResearch Institute of Epidemiology, Microbiology and Infectious Diseases, UzbekistanNULLActive, not recruiting18 Years90 YearsAll300Phase 1;Phase 2NULL